Research progress of CD39-CD73-adenosine pathway in immune regulation of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) patients accounts for 85%-90% of all primary liver cancer patients. Surgical treatment methods, represented by resection and liver transplantation, have relatively good efficacy and are currently the preferred treatment approaches for HCC, with a 5-year survival rate o...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2024-12-01
|
Series: | Zhongguo Linchuang Yixue |
Subjects: | |
Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2024.20240056 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|